| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0021 | 1 |